The Causes of Delay to Diagnosis the Cancer of Bladder in Patients with Symptoms

Document Type : Original Article (s)

Authors

1 Student of Medicine, Student Research Committee, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Associate Professor, Department of Urology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Secondary prevention, as defined by early diagnosis, has very important role in response to treatment and reduction of complication of bladder cancer. In this study we sought to investigate the interval between onset of symptoms and definite diagnosis and their related factors.Methods: This study was done on 82 patients extracted from cancer registry.Findings: Mean interval between onset of symptoms and definite diagnosis was 3.8 months. Mean delay from onset of symptoms to first medical visit was 2.76 months and mean GPs delay in making a patient refer to urologist was 0.98 months. Conclusion: The present study revealed patients' late referral to physicians and general physicians' delay in referring the patients as two major factors in delayed diagnosis. This finding emphasizes the importance of public information provision about early referral after the onset of symptoms, as well as promoted education for general physicians.

Keywords

References

  1. Olsen J, Chongsuvivatwong V, Beaglehole R. Prevention and control of chronic,non-comunicable diseases. In: Detels R, McEwen J, Beaglehole R, Tanaka H, editors. Oxford Textbook of Public Health. 5th ed. Oxford: Oxford University Press; 2009.
  2. Spurgeon P, Barwell F, Kerr D. Waiting times for cancer patients in England after general practitioners' referrals: retrospective national survey. BMJ 2000; 320(7238): 838-9.
  3. Barrett J, Hamilton W. Pathways to the diagnosis of lung cancer in the UK: a cohort study. BMC Fam Pract 2008; 9: 31.
  4. Jacobs BL, Lee CT, Montie JE. Bladder cancer in 2010: how far have we come? CA Cancer J Clin 2010; 60(4): 244-72.
  5. Bruyninckx R, Buntinx F, Aertgeerts B, Van C, V. The diagnostic value of macroscopic haematuria for the diagnosis of urological cancer in general practice. Br J Gen Pract 2003; 53(486): 31-5.
  6. Summerton N, Mann S, Rigby AS, Ashley J, Palmer S, Hetherington JW. Patients with new onset haematuria: assessing the discriminant value of clinical information in relation to urological malignancies. Br J Gen Pract 2002; 52(477): 284-9.
  7. Messing EM. Urothelial tumors of the bladder. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh Urology. 9th ed. Philadelphia: WB. Saunders; 2006. p. 2407-44.
  8. Liedberg F, Anderson H, Mansson A, Mansson W. Diagnostic delay and prognosis in invasive bladder cancer. Scand J Urol Nephrol 2003; 37(5): 396-400.
  9. Fahmy NM, Mahmud S, Aprikian AG. Delay in the surgical treatment of bladder cancer and survival: systematic review of the literature. Eur Urol 2006; 50(6): 1176-82.
  10. Chang SS, Hassan JM, Cookson MS, Wells N, Smith JA, Jr. Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage. J Urol 2003; 170(4 Pt 1): 1085-7.
  11. Mahmud SM, Fong B, Fahmy N, Tanguay S, Aprikian AG. Effect of preoperative delay on survival in patients with bladder cancer undergoing cystectomy in Quebec: a population based study. J Urol 2006; 175(1): 78-83.
  12. Fahmy N, Kassouf W, Jeyaganth S, Amin M, Mahmud S, Steinberg J, et al. An analysis of preoperative delays prior to radical cystectomy for bladder cancer in Quebec. Can Urol Assoc J 2008; 2(2): 102-8.
  13. Wallace DM, Bryan RT, Dunn JA, Begum G, Bathers S. Delay and survival in bladder cancer. BJU Int 2002; 89(9): 868-78.
  14. Kolahdoozan Sh, Sadjadi A, Khademi H. Five Common Cancers in Iran. Arch Iran Med 2010; 13(2): 143-6.
  15. Yavari P, Sadrolhefazi B, Mohagheghi MA, Madani H, Mosavizadeh A, Nahvijou A, et al. An epidemiological analysis of cancer data in an Iranian hospital during the last three decades. Asian Pac J Cancer Prev 2008; 9(1): 145-50.
  16. Sadjadi A, Nouraie M, Mohagheghi MA, Mousavi-Jarrahi A, Malekezadeh R, Parkin DM. Cancer occurrence in Iran in 2002, an international perspective. Asian Pac J Cancer Prev 2005; 6(3): 359-63.
  17. Porter MP. Examining the association between delay in diagnosis and decreased survival in bladder cancer. Cancer 2010; 116(22): 5122-5.
  18. NICE Referral Guidelines for Suspected Cancer. London: NICE; 2005.
  19. American Cancer Society. Cancer Facts & Figures. Atlanta: American Cancer Society; 2006.
  20. Mungan NA, Aben KK, Schoenberg MP, Visser O, Coebergh JW, Witjes JA, et al. Gender differences in stage-adjusted bladder cancer survival. Urology 2000; 55(6): 876-80.
Journal of Isfahan Medical School
Volume 29, Issue 152 - Serial Number 152
July and August 2011
Pages 1242-1247

Files

History

  • Receive Date: 19 July 2011
  • Revise Date: 01 November 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics